124 related articles for article (PubMed ID: 37150450)
1. CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
von Knebel Doeberitz N; Kroh F; Breitling J; König L; Maksimovic S; Graß S; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Radiother Oncol; 2023 Jul; 184():109694. PubMed ID: 37150450
[TBL] [Abstract][Full Text] [Related]
2. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
[TBL] [Abstract][Full Text] [Related]
3. Post-Surgical Depositions of Blood Products Are No Major Confounder for the Diagnostic and Prognostic Performance of CEST MRI in Patients with Glioma.
von Knebel Doeberitz N; Kroh F; König L; Boyd PS; Graß S; Bauspieß C; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Goerke S; Korzowski A; Paech D
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760790
[TBL] [Abstract][Full Text] [Related]
4. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
5. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
[TBL] [Abstract][Full Text] [Related]
6. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
[TBL] [Abstract][Full Text] [Related]
7. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.
Wu Y; Wood TC; Arzanforoosh F; Hernandez-Tamames JA; Barker GJ; Smits M; Warnert EAH
MAGMA; 2022 Feb; 35(1):63-73. PubMed ID: 34994858
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
9. Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T.
Xu X; Yadav NN; Zeng H; Jones CK; Zhou J; van Zijl PC; Xu J
Magn Reson Med; 2016 Jan; 75(1):88-96. PubMed ID: 26445350
[TBL] [Abstract][Full Text] [Related]
10. Isolation of amide proton transfer effect and relayed nuclear Overhauser enhancement effect at -3.5ppm using CEST with double saturation powers.
Zhao Y; Sun C; Zu Z
Magn Reson Med; 2023 Sep; 90(3):1025-1040. PubMed ID: 37154382
[TBL] [Abstract][Full Text] [Related]
11. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma.
Wamelink IJHG; Kuijer JPA; Padrela BE; Zhang Y; Barkhof F; Mutsaerts HJMM; Petr J; van de Giessen E; Keil VC
J Magn Reson Imaging; 2023 Jan; 57(1):206-215. PubMed ID: 35633282
[TBL] [Abstract][Full Text] [Related]
13. Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI.
Sun PZ
Magn Reson Med; 2023 May; 89(5):2014-2023. PubMed ID: 36579767
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 Tesla.
Heo HY; Zhang Y; Lee DH; Hong X; Zhou J
Magn Reson Med; 2016 Jan; 75(1):137-49. PubMed ID: 25753614
[TBL] [Abstract][Full Text] [Related]
15. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
[TBL] [Abstract][Full Text] [Related]
16. Clinical routine acquisition protocol for 3D relaxation-compensated APT and rNOE CEST-MRI of the human brain at 3T.
Goerke S; Breitling J; Korzowski A; Paech D; Zaiss M; Schlemmer HP; Ladd ME; Bachert P
Magn Reson Med; 2021 Jul; 86(1):393-404. PubMed ID: 33586217
[TBL] [Abstract][Full Text] [Related]
17. Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla.
Scheidegger R; Wong ET; Alsop DC
Neuroimage; 2014 Oct; 99():256-68. PubMed ID: 24857712
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the effects of water proton concentration and water T
Lee DH; Heo HY; Zhang K; Zhang Y; Jiang S; Zhao X; Zhou J
Magn Reson Med; 2017 Feb; 77(2):855-863. PubMed ID: 26841096
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
20. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
